ATLAS fair value
ATLAS has no fair value for this stock today.
Jupiter Life Line Hospitals share price today, ATLAS forecast and fair value
Healthcare · Medical Care Facilities · National Stock Exchange of India · India
Prices as of Oct 26, 2026 · INR
ATLAS has no fair value for this stock today.
52%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives Jupiter Life Line Hospitals a 52% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₹241.91 and ₹265.92; in 9 out of 10, between ₹222.44 and ₹289.20. Estimated annual volatility is 27%.
ATLAS does not publish a fair value for JLHL.NSE right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks JLHL.NSE has traded between ₹233.40 and ₹340.00. Today it is 25.6% below that high and 8% above its low.
On the business: net margin is 12.0%; it trades at 44.4 times earnings.
Its beta is 0.12: it tends to move less than the market.
Jupiter Life Line Hospitals Limited is a premier healthcare provider operating a network of hospitals across India.
Want to see everything about Jupiter Life Line Hospitals?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
Jupiter Life Line Hospitals Limited is a premier healthcare provider operating a network of hospitals across India.
52%: close to a coin flip. In half of the simulated outcomes, JLHL.NSE ends the month between ₹241.91 and ₹265.92.
Jupiter Life Line Hospitals's market capitalization is ₹80.0B. Its price-to-earnings (P/E) ratio is 44.4: you pay ₹44.4 for each ₹1.00 of yearly earnings.
Yes. JLHL.NSE's current dividend yield is 0.32% at today's price (₹252.95).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy